All Stories

  1. FGFR3 – a Central Player in Bladder Cancer Pathogenesis?
  2. Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency
  3. Bladder cancer
  4. A place for precision medicine in bladder cancer: targeting the FGFRs
  5. ETV5 as a mediator of the oncogenic effects of mutant FGFR3 in bladder cancer
  6. Molecular pathways of bladder cancer
  7. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
  8. Molecular Subtyping of Invasive Bladder Cancer: Time to Divide and Rule?
  9. Oncogenic FGFR3 gene fusions in bladder cancer
  10. A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges
  11. Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium
  12. Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer
  13. Molecular pathogenesis of bladder cancer
  14. Novel therapeutic targets in bladder cancer: mutation and expression of FGF receptors
  15. Bladder cancer subtypes defined by genomic alterations
  16. Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer
  17. Tumor suppressor loci in bladder cancer
  18. FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer
  19. Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
  20. What we could do now: molecular pathology of bladder cancer
  21. Negative regulation of G1/S transition by the candidate bladder tumour suppressor gene DBCCR1
  22. Redefining a critical region of LOH on 4p16.3 in bladder cancer
  23. Mutation of the 9q34 gene TSC1 in sporadic bladder cancer
  24. Identification of novel bladder tumour suppressor genes
  25. Identification of novel bladder tumour suppressor genes
  26. Deletion mapping of chromosome II in carcinoma of the bladder
  27. The spectrum of TP53 mutations in bladder carcinoma
  28. Genetic alterations in bladder cancer
  29. Immunocytochemical localization ofc-erbB-2 protein in transitional cell carcinoma of the urinary bladder
  30. Molecular Biology of Bladder Cancer
  31. The genetics of bladder cancer